These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11485401)

  • 1. UDP-galactose transporter is required for Theiler's virus entry into mammalian cells.
    Hertzler S; Kallio P; Lipton HL
    Virology; 2001 Aug; 286(2):336-44. PubMed ID: 11485401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential usage of carbohydrate co-receptors influences cellular tropism of Theiler's murine encephalomyelitis virus infection of the central nervous system.
    Lipton HL; Kumar AS; Hertzler S; Reddi HV
    Glycoconj J; 2006 Feb; 23(1-2):39-49. PubMed ID: 16575521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactose is needed only for expression of co-receptors used by Theiler's murine encephalomyelitis virus as the virus does not directly bind galactose or use the UDP-galactose transporter as a receptor.
    Reddi HV; Kallio P; Lipton HL
    J Gen Virol; 2003 Apr; 84(Pt 4):845-849. PubMed ID: 12655085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence.
    Luo M; Toth KS; Zhou L; Pritchard A; Lipton HL
    Virology; 1996 Jun; 220(1):246-50. PubMed ID: 8659122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.
    Obuchi M; Ohara Y
    Jpn J Infect Dis; 1999 Dec; 52(6):228-33. PubMed ID: 10738359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered cell growth and morphology in a BHK-21 cell mutant that lacks a receptor for Theiler's murine encephalomyelitis virus.
    Libbey JE; Tsunoda I; Fujinami RS
    Virology; 2002 Mar; 294(1):85-93. PubMed ID: 11886268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of peritoneal macrophages to infection by Theiler's virus.
    Jelachich ML; Reddi HV; Trottier MD; Schlitt BP; Lipton HL
    Virus Res; 2004 Sep; 104(2):123-7. PubMed ID: 15246649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theiler's murine encephalomyelitis virus in nonbarrier rat colonies.
    Rodrigues DM; Martins SS; Gilioli R; Guaraldo AM; Gatti MS
    Comp Med; 2005 Oct; 55(5):459-64. PubMed ID: 16270903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of neurovirulence of Theiler's murine encephalomyelitis virus strain GDVII is not sufficient to establish persistence in the central nervous system.
    Lipton HL; Pritchard AE; Calenoff MA
    J Gen Virol; 1998 May; 79 ( Pt 5)():1001-4. PubMed ID: 9603314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment.
    Shah AH; Lipton HL
    Virology; 2002 Dec; 304(2):443-50. PubMed ID: 12504583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and characterization of a BHK-21 cell line resistant to infection by Theiler's murine encephalomyelitis virus due to a block in virus attachment and entry.
    Hertzler S; Trottier M; Lipton HL
    J Gen Virol; 2000 Oct; 81(Pt 10):2485-2490. PubMed ID: 10993937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.
    Jnaoui K; Minet M; Michiels T
    J Virol; 2002 Aug; 76(16):8138-47. PubMed ID: 12134019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses.
    Reddi HV; Lipton HL
    J Virol; 2002 Aug; 76(16):8400-7. PubMed ID: 12134043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus.
    Michiels T; Jarousse N; Brahic M
    Virology; 1995 Dec; 214(2):550-8. PubMed ID: 8553557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis.
    Reddi HV; Kumar AS; Kung AY; Kallio PD; Schlitt BP; Lipton HL
    J Virol; 2004 Aug; 78(16):8909-16. PubMed ID: 15280499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sialyloligosaccharide binding in Theiler's virus persistence.
    Zhou L; Lin X; Green TJ; Lipton HL; Luo M
    J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theiler's virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains.
    Rubio N; Sanz-Rodriguez F; Lipton HL
    Cell Immunol; 2006 Jan; 239(1):31-40. PubMed ID: 16684516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
    Senkowski A; Shim B; Roos RP
    J Neurovirol; 1995 Mar; 1(1):101-10. PubMed ID: 9222346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theiler's murine encephalomyelitis virus infection induces early expression of c-fos in astrocytes.
    Rubio N; Martin-Clemente B
    Virology; 1999 May; 258(1):21-9. PubMed ID: 10329564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.
    Jnaoui K; Michiels T
    Virology; 1998 May; 244(2):397-404. PubMed ID: 9601508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.